Beautyfarm Medical (02373) has issued an announcement regarding the utilization of its idle capital. On July 14, through its wholly-owned subsidiary, Beautyfarm (Hong Kong), the company subscribed for a financial product from Citibank with a total value of RMB 285 million, based on the subscription terms of that date.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments